Further literature review revealed that LHX9 is a common transcription factor in the LHX family, which can participate in the progression of osteosarcoma, glioma, and ovarian cancer, and is closely associated with the glycolytic reprogramming of glioma and ovarian cancer [13, 15, 20]. This evidence concerns the gene RAB2A and ovarian carcinoma.